EC
FLXN

EcoR1 Capital’s Flexion Therapeutics, Inc. FLXN Stock Holding History

EcoR1 Capital’s Portfolio FLXN Stock Details FLXN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q2 		– Sell
-162,900
Closed -$3.67M – 31
2015
Q1 		$3.67M Buy
+162,900
New +$3.77M 1.22% 21

Other funds holding FLXN

GGHC
Gilder Gagnon Howe & Co New York $9.69B AUM 55.7% 1-Year Est. Return
NHAS
Novo Holdings A/S Hellerup, Denmark $1.72B AUM 106.92% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
KCM
Kingdon Capital Management New York $976M AUM 66.76% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
BC
Broadfin Capital New York $747M AUM 100.56% 1-Year Est. Return
Schroder Investment Management Group
Schroder Investment Management Group London, United Kingdom $141B AUM 34.18% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return

EcoR1 Capital's FLXN Position: Q2 2015 in Review

EcoR1 Capital sold out of Flexion Therapeutics, Inc. (FLXN) in Q2 2015, closing a stake of 162,900 shares — an estimated $3.67M sold.

EcoR1 Capital first reported a position in FLXN in Q1 2015 and held it in 1 quarter. The position peaked at $3.67M in Q1 2015. 61 funds tracked by Wall St. Rank hold FLXN as of Q2 2015.

  • EcoR1 Capital reported no remaining Flexion Therapeutics, Inc. position as of Q2 2015 after selling out during the quarter.
  • EcoR1 Capital sold 162,900 Flexion Therapeutics, Inc. shares in Q2 2015, an estimated $3.67M.
  • EcoR1 Capital first reported a position in Flexion Therapeutics, Inc. in Q1 2015 and held it in 1 quarter.
  • EcoR1 Capital's Flexion Therapeutics, Inc. position peaked at $3.67M in Q1 2015.
  • 61 funds tracked by Wall St. Rank held Flexion Therapeutics, Inc. as of Q2 2015.

Based on EcoR1 Capital's 13F filing for Q2 2015, filed 14 Aug 2015.